The global Targeted Drug Delivery System market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
Targeted Drug Delivery System is a technology used to precisely deliver drugs to specific target areas. This system is designed to increase the efficacy of the drug and reduce its impact on surrounding healthy tissue. Typically, this involves using carriers or nanoparticles to encapsulate the drug so that it can be delivered more precisely to diseased tissue or target sites.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Targeted Drug Delivery System market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Targeted Drug Delivery System market size and forecasts, in consumption value ($ Million), 2020-2031
Global Targeted Drug Delivery System market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Targeted Drug Delivery System market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Targeted Drug Delivery System market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Targeted Drug Delivery System
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Targeted Drug Delivery System market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include 3M Company, Abbott Laboratories, Ablynx NV, Aciont Inc, Acrux, Agilis BiOthersapeutics LLC, Aileron Therapeutics Inc, Nano Precision Medical Inc, Novartis Pharmaceuticals Corp, Oxford Biomedica, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 segmentation
Targeted Drug Delivery System market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Nano Tubes
Nano Wires
Nano Shells
Quantum Dots
Nano Pros
麻豆原创 segment by Application
First Order Targeting (Organ Compartmentalization)
Second Order Targeting (Cellular Targeting)
Third Order Targeting (Intracellular Targeting)
麻豆原创 segment by players, this report covers
3M Company
Abbott Laboratories
Ablynx NV
Aciont Inc
Acrux
Agilis BiOthersapeutics LLC
Aileron Therapeutics Inc
Nano Precision Medical Inc
Novartis Pharmaceuticals Corp
Oxford Biomedica
PharmaIN Corp
PolyMicrospheres
Presage Biosciences Inc
Pulmatrix Inc
Quark Pharmaceuticals Inc
RegeneRx Biopharmaceuticals Inc
Replicor Inc
Rexahn Pharmaceuticals Inc
Roche Holding AG
Savara Inc
Serina Therapeutics Inc.
Silenseed Ltd.
SoluBest Ltd
Suda Ltd
Taiwan Liposome Co. Ltd.
Pipeline
Vect-Horus S.A.S.
Vectura Group plc
WAVE Life Sciences Pvt. Ltd.
Xigen SA
麻豆原创 segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Targeted Drug Delivery System product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Targeted Drug Delivery System, with revenue, gross margin, and global market share of Targeted Drug Delivery System from 2020 to 2025.
Chapter 3, the Targeted Drug Delivery System competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Targeted Drug Delivery System market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Targeted Drug Delivery System.
Chapter 13, to describe Targeted Drug Delivery System research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 Classification of Targeted Drug Delivery System by Type
1.3.1 Overview: Global Targeted Drug Delivery System 麻豆原创 Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Targeted Drug Delivery System Consumption Value 麻豆原创 Share by Type in 2024
1.3.3 Nano Tubes
1.3.4 Nano Wires
1.3.5 Nano Shells
1.3.6 Quantum Dots
1.3.7 Nano Pros
1.4 Global Targeted Drug Delivery System 麻豆原创 by Application
1.4.1 Overview: Global Targeted Drug Delivery System 麻豆原创 Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 First Order Targeting (Organ Compartmentalization)
1.4.3 Second Order Targeting (Cellular Targeting)
1.4.4 Third Order Targeting (Intracellular Targeting)
1.5 Global Targeted Drug Delivery System 麻豆原创 Size & Forecast
1.6 Global Targeted Drug Delivery System 麻豆原创 Size and Forecast by Region
1.6.1 Global Targeted Drug Delivery System 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Targeted Drug Delivery System 麻豆原创 Size by Region, (2020-2031)
1.6.3 North America Targeted Drug Delivery System 麻豆原创 Size and Prospect (2020-2031)
1.6.4 Europe Targeted Drug Delivery System 麻豆原创 Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Targeted Drug Delivery System 麻豆原创 Size and Prospect (2020-2031)
1.6.6 South America Targeted Drug Delivery System 麻豆原创 Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Targeted Drug Delivery System 麻豆原创 Size and Prospect (2020-2031)
2 Company Profiles
2.1 3M Company
2.1.1 3M Company Details
2.1.2 3M Company Major Business
2.1.3 3M Company Targeted Drug Delivery System Product and Solutions
2.1.4 3M Company Targeted Drug Delivery System Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.1.5 3M Company Recent Developments and Future Plans
2.2 Abbott Laboratories
2.2.1 Abbott Laboratories Details
2.2.2 Abbott Laboratories Major Business
2.2.3 Abbott Laboratories Targeted Drug Delivery System Product and Solutions
2.2.4 Abbott Laboratories Targeted Drug Delivery System Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.2.5 Abbott Laboratories Recent Developments and Future Plans
2.3 Ablynx NV
2.3.1 Ablynx NV Details
2.3.2 Ablynx NV Major Business
2.3.3 Ablynx NV Targeted Drug Delivery System Product and Solutions
2.3.4 Ablynx NV Targeted Drug Delivery System Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.3.5 Ablynx NV Recent Developments and Future Plans
2.4 Aciont Inc
2.4.1 Aciont Inc Details
2.4.2 Aciont Inc Major Business
2.4.3 Aciont Inc Targeted Drug Delivery System Product and Solutions
2.4.4 Aciont Inc Targeted Drug Delivery System Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.4.5 Aciont Inc Recent Developments and Future Plans
2.5 Acrux
2.5.1 Acrux Details
2.5.2 Acrux Major Business
2.5.3 Acrux Targeted Drug Delivery System Product and Solutions
2.5.4 Acrux Targeted Drug Delivery System Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.5.5 Acrux Recent Developments and Future Plans
2.6 Agilis BiOthersapeutics LLC
2.6.1 Agilis BiOthersapeutics LLC Details
2.6.2 Agilis BiOthersapeutics LLC Major Business
2.6.3 Agilis BiOthersapeutics LLC Targeted Drug Delivery System Product and Solutions
2.6.4 Agilis BiOthersapeutics LLC Targeted Drug Delivery System Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.6.5 Agilis BiOthersapeutics LLC Recent Developments and Future Plans
2.7 Aileron Therapeutics Inc
2.7.1 Aileron Therapeutics Inc Details
2.7.2 Aileron Therapeutics Inc Major Business
2.7.3 Aileron Therapeutics Inc Targeted Drug Delivery System Product and Solutions
2.7.4 Aileron Therapeutics Inc Targeted Drug Delivery System Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.7.5 Aileron Therapeutics Inc Recent Developments and Future Plans
2.8 Nano Precision Medical Inc
2.8.1 Nano Precision Medical Inc Details
2.8.2 Nano Precision Medical Inc Major Business
2.8.3 Nano Precision Medical Inc Targeted Drug Delivery System Product and Solutions
2.8.4 Nano Precision Medical Inc Targeted Drug Delivery System Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.8.5 Nano Precision Medical Inc Recent Developments and Future Plans
2.9 Novartis Pharmaceuticals Corp
2.9.1 Novartis Pharmaceuticals Corp Details
2.9.2 Novartis Pharmaceuticals Corp Major Business
2.9.3 Novartis Pharmaceuticals Corp Targeted Drug Delivery System Product and Solutions
2.9.4 Novartis Pharmaceuticals Corp Targeted Drug Delivery System Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.9.5 Novartis Pharmaceuticals Corp Recent Developments and Future Plans
2.10 Oxford Biomedica
2.10.1 Oxford Biomedica Details
2.10.2 Oxford Biomedica Major Business
2.10.3 Oxford Biomedica Targeted Drug Delivery System Product and Solutions
2.10.4 Oxford Biomedica Targeted Drug Delivery System Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.10.5 Oxford Biomedica Recent Developments and Future Plans
2.11 PharmaIN Corp
2.11.1 PharmaIN Corp Details
2.11.2 PharmaIN Corp Major Business
2.11.3 PharmaIN Corp Targeted Drug Delivery System Product and Solutions
2.11.4 PharmaIN Corp Targeted Drug Delivery System Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.11.5 PharmaIN Corp Recent Developments and Future Plans
2.12 PolyMicrospheres
2.12.1 PolyMicrospheres Details
2.12.2 PolyMicrospheres Major Business
2.12.3 PolyMicrospheres Targeted Drug Delivery System Product and Solutions
2.12.4 PolyMicrospheres Targeted Drug Delivery System Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.12.5 PolyMicrospheres Recent Developments and Future Plans
2.13 Presage Biosciences Inc
2.13.1 Presage Biosciences Inc Details
2.13.2 Presage Biosciences Inc Major Business
2.13.3 Presage Biosciences Inc Targeted Drug Delivery System Product and Solutions
2.13.4 Presage Biosciences Inc Targeted Drug Delivery System Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.13.5 Presage Biosciences Inc Recent Developments and Future Plans
2.14 Pulmatrix Inc
2.14.1 Pulmatrix Inc Details
2.14.2 Pulmatrix Inc Major Business
2.14.3 Pulmatrix Inc Targeted Drug Delivery System Product and Solutions
2.14.4 Pulmatrix Inc Targeted Drug Delivery System Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.14.5 Pulmatrix Inc Recent Developments and Future Plans
2.15 Quark Pharmaceuticals Inc
2.15.1 Quark Pharmaceuticals Inc Details
2.15.2 Quark Pharmaceuticals Inc Major Business
2.15.3 Quark Pharmaceuticals Inc Targeted Drug Delivery System Product and Solutions
2.15.4 Quark Pharmaceuticals Inc Targeted Drug Delivery System Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.15.5 Quark Pharmaceuticals Inc Recent Developments and Future Plans
2.16 RegeneRx Biopharmaceuticals Inc
2.16.1 RegeneRx Biopharmaceuticals Inc Details
2.16.2 RegeneRx Biopharmaceuticals Inc Major Business
2.16.3 RegeneRx Biopharmaceuticals Inc Targeted Drug Delivery System Product and Solutions
2.16.4 RegeneRx Biopharmaceuticals Inc Targeted Drug Delivery System Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.16.5 RegeneRx Biopharmaceuticals Inc Recent Developments and Future Plans
2.17 Replicor Inc
2.17.1 Replicor Inc Details
2.17.2 Replicor Inc Major Business
2.17.3 Replicor Inc Targeted Drug Delivery System Product and Solutions
2.17.4 Replicor Inc Targeted Drug Delivery System Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.17.5 Replicor Inc Recent Developments and Future Plans
2.18 Rexahn Pharmaceuticals Inc
2.18.1 Rexahn Pharmaceuticals Inc Details
2.18.2 Rexahn Pharmaceuticals Inc Major Business
2.18.3 Rexahn Pharmaceuticals Inc Targeted Drug Delivery System Product and Solutions
2.18.4 Rexahn Pharmaceuticals Inc Targeted Drug Delivery System Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.18.5 Rexahn Pharmaceuticals Inc Recent Developments and Future Plans
2.19 Roche Holding AG
2.19.1 Roche Holding AG Details
2.19.2 Roche Holding AG Major Business
2.19.3 Roche Holding AG Targeted Drug Delivery System Product and Solutions
2.19.4 Roche Holding AG Targeted Drug Delivery System Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.19.5 Roche Holding AG Recent Developments and Future Plans
2.20 Savara Inc
2.20.1 Savara Inc Details
2.20.2 Savara Inc Major Business
2.20.3 Savara Inc Targeted Drug Delivery System Product and Solutions
2.20.4 Savara Inc Targeted Drug Delivery System Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.20.5 Savara Inc Recent Developments and Future Plans
2.21 Serina Therapeutics Inc.
2.21.1 Serina Therapeutics Inc. Details
2.21.2 Serina Therapeutics Inc. Major Business
2.21.3 Serina Therapeutics Inc. Targeted Drug Delivery System Product and Solutions
2.21.4 Serina Therapeutics Inc. Targeted Drug Delivery System Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.21.5 Serina Therapeutics Inc. Recent Developments and Future Plans
2.22 Silenseed Ltd.
2.22.1 Silenseed Ltd. Details
2.22.2 Silenseed Ltd. Major Business
2.22.3 Silenseed Ltd. Targeted Drug Delivery System Product and Solutions
2.22.4 Silenseed Ltd. Targeted Drug Delivery System Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.22.5 Silenseed Ltd. Recent Developments and Future Plans
2.23 SoluBest Ltd
2.23.1 SoluBest Ltd Details
2.23.2 SoluBest Ltd Major Business
2.23.3 SoluBest Ltd Targeted Drug Delivery System Product and Solutions
2.23.4 SoluBest Ltd Targeted Drug Delivery System Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.23.5 SoluBest Ltd Recent Developments and Future Plans
2.24 Suda Ltd
2.24.1 Suda Ltd Details
2.24.2 Suda Ltd Major Business
2.24.3 Suda Ltd Targeted Drug Delivery System Product and Solutions
2.24.4 Suda Ltd Targeted Drug Delivery System Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.24.5 Suda Ltd Recent Developments and Future Plans
2.25 Taiwan Liposome Co. Ltd.
2.25.1 Taiwan Liposome Co. Ltd. Details
2.25.2 Taiwan Liposome Co. Ltd. Major Business
2.25.3 Taiwan Liposome Co. Ltd. Targeted Drug Delivery System Product and Solutions
2.25.4 Taiwan Liposome Co. Ltd. Targeted Drug Delivery System Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.25.5 Taiwan Liposome Co. Ltd. Recent Developments and Future Plans
2.26 Pipeline
2.26.1 Pipeline Details
2.26.2 Pipeline Major Business
2.26.3 Pipeline Targeted Drug Delivery System Product and Solutions
2.26.4 Pipeline Targeted Drug Delivery System Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.26.5 Pipeline Recent Developments and Future Plans
2.27 Vect-Horus S.A.S.
2.27.1 Vect-Horus S.A.S. Details
2.27.2 Vect-Horus S.A.S. Major Business
2.27.3 Vect-Horus S.A.S. Targeted Drug Delivery System Product and Solutions
2.27.4 Vect-Horus S.A.S. Targeted Drug Delivery System Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.27.5 Vect-Horus S.A.S. Recent Developments and Future Plans
2.28 Vectura Group plc
2.28.1 Vectura Group plc Details
2.28.2 Vectura Group plc Major Business
2.28.3 Vectura Group plc Targeted Drug Delivery System Product and Solutions
2.28.4 Vectura Group plc Targeted Drug Delivery System Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.28.5 Vectura Group plc Recent Developments and Future Plans
2.29 WAVE Life Sciences Pvt. Ltd.
2.29.1 WAVE Life Sciences Pvt. Ltd. Details
2.29.2 WAVE Life Sciences Pvt. Ltd. Major Business
2.29.3 WAVE Life Sciences Pvt. Ltd. Targeted Drug Delivery System Product and Solutions
2.29.4 WAVE Life Sciences Pvt. Ltd. Targeted Drug Delivery System Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.29.5 WAVE Life Sciences Pvt. Ltd. Recent Developments and Future Plans
2.30 Xigen SA
2.30.1 Xigen SA Details
2.30.2 Xigen SA Major Business
2.30.3 Xigen SA Targeted Drug Delivery System Product and Solutions
2.30.4 Xigen SA Targeted Drug Delivery System Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.30.5 Xigen SA Recent Developments and Future Plans
3 麻豆原创 Competition, by Players
3.1 Global Targeted Drug Delivery System Revenue and Share by Players (2020-2025)
3.2 麻豆原创 Share Analysis (2024)
3.2.1 麻豆原创 Share of Targeted Drug Delivery System by Company Revenue
3.2.2 Top 3 Targeted Drug Delivery System Players 麻豆原创 Share in 2024
3.2.3 Top 6 Targeted Drug Delivery System Players 麻豆原创 Share in 2024
3.3 Targeted Drug Delivery System 麻豆原创: Overall Company Footprint Analysis
3.3.1 Targeted Drug Delivery System 麻豆原创: Region Footprint
3.3.2 Targeted Drug Delivery System 麻豆原创: Company Product Type Footprint
3.3.3 Targeted Drug Delivery System 麻豆原创: Company Product Application Footprint
3.4 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 麻豆原创 Size Segment by Type
4.1 Global Targeted Drug Delivery System Consumption Value and 麻豆原创 Share by Type (2020-2025)
4.2 Global Targeted Drug Delivery System 麻豆原创 Forecast by Type (2026-2031)
5 麻豆原创 Size Segment by Application
5.1 Global Targeted Drug Delivery System Consumption Value 麻豆原创 Share by Application (2020-2025)
5.2 Global Targeted Drug Delivery System 麻豆原创 Forecast by Application (2026-2031)
6 North America
6.1 North America Targeted Drug Delivery System Consumption Value by Type (2020-2031)
6.2 North America Targeted Drug Delivery System 麻豆原创 Size by Application (2020-2031)
6.3 North America Targeted Drug Delivery System 麻豆原创 Size by Country
6.3.1 North America Targeted Drug Delivery System Consumption Value by Country (2020-2031)
6.3.2 United States Targeted Drug Delivery System 麻豆原创 Size and Forecast (2020-2031)
6.3.3 Canada Targeted Drug Delivery System 麻豆原创 Size and Forecast (2020-2031)
6.3.4 Mexico Targeted Drug Delivery System 麻豆原创 Size and Forecast (2020-2031)
7 Europe
7.1 Europe Targeted Drug Delivery System Consumption Value by Type (2020-2031)
7.2 Europe Targeted Drug Delivery System Consumption Value by Application (2020-2031)
7.3 Europe Targeted Drug Delivery System 麻豆原创 Size by Country
7.3.1 Europe Targeted Drug Delivery System Consumption Value by Country (2020-2031)
7.3.2 Germany Targeted Drug Delivery System 麻豆原创 Size and Forecast (2020-2031)
7.3.3 France Targeted Drug Delivery System 麻豆原创 Size and Forecast (2020-2031)
7.3.4 United Kingdom Targeted Drug Delivery System 麻豆原创 Size and Forecast (2020-2031)
7.3.5 Russia Targeted Drug Delivery System 麻豆原创 Size and Forecast (2020-2031)
7.3.6 Italy Targeted Drug Delivery System 麻豆原创 Size and Forecast (2020-2031)
8 Asia-Pacific
8.1 Asia-Pacific Targeted Drug Delivery System Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Targeted Drug Delivery System Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Targeted Drug Delivery System 麻豆原创 Size by Region
8.3.1 Asia-Pacific Targeted Drug Delivery System Consumption Value by Region (2020-2031)
8.3.2 China Targeted Drug Delivery System 麻豆原创 Size and Forecast (2020-2031)
8.3.3 Japan Targeted Drug Delivery System 麻豆原创 Size and Forecast (2020-2031)
8.3.4 South Korea Targeted Drug Delivery System 麻豆原创 Size and Forecast (2020-2031)
8.3.5 India Targeted Drug Delivery System 麻豆原创 Size and Forecast (2020-2031)
8.3.6 Southeast Asia Targeted Drug Delivery System 麻豆原创 Size and Forecast (2020-2031)
8.3.7 Australia Targeted Drug Delivery System 麻豆原创 Size and Forecast (2020-2031)
9 South America
9.1 South America Targeted Drug Delivery System Consumption Value by Type (2020-2031)
9.2 South America Targeted Drug Delivery System Consumption Value by Application (2020-2031)
9.3 South America Targeted Drug Delivery System 麻豆原创 Size by Country
9.3.1 South America Targeted Drug Delivery System Consumption Value by Country (2020-2031)
9.3.2 Brazil Targeted Drug Delivery System 麻豆原创 Size and Forecast (2020-2031)
9.3.3 Argentina Targeted Drug Delivery System 麻豆原创 Size and Forecast (2020-2031)
10 Middle East & Africa
10.1 Middle East & Africa Targeted Drug Delivery System Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Targeted Drug Delivery System Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Targeted Drug Delivery System 麻豆原创 Size by Country
10.3.1 Middle East & Africa Targeted Drug Delivery System Consumption Value by Country (2020-2031)
10.3.2 Turkey Targeted Drug Delivery System 麻豆原创 Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Targeted Drug Delivery System 麻豆原创 Size and Forecast (2020-2031)
10.3.4 UAE Targeted Drug Delivery System 麻豆原创 Size and Forecast (2020-2031)
11 麻豆原创 Dynamics
11.1 Targeted Drug Delivery System 麻豆原创 Drivers
11.2 Targeted Drug Delivery System 麻豆原创 Restraints
11.3 Targeted Drug Delivery System Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Targeted Drug Delivery System Industry Chain
12.2 Targeted Drug Delivery System Upstream Analysis
12.3 Targeted Drug Delivery System Midstream Analysis
12.4 Targeted Drug Delivery System Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
3M Company
Abbott Laboratories
Ablynx NV
Aciont Inc
Acrux
Agilis BiOthersapeutics LLC
Aileron Therapeutics Inc
Nano Precision Medical Inc
Novartis Pharmaceuticals Corp
Oxford Biomedica
PharmaIN Corp
PolyMicrospheres
Presage Biosciences Inc
Pulmatrix Inc
Quark Pharmaceuticals Inc
RegeneRx Biopharmaceuticals Inc
Replicor Inc
Rexahn Pharmaceuticals Inc
Roche Holding AG
Savara Inc
Serina Therapeutics Inc.
Silenseed Ltd.
SoluBest Ltd
Suda Ltd
Taiwan Liposome Co. Ltd.
Pipeline
Vect-Horus S.A.S.
Vectura Group plc
WAVE Life Sciences Pvt. Ltd.
Xigen SA
听
听
*If Applicable.
